1. Home
  2. POOL vs TECH Comparison

POOL vs TECH Comparison

Compare POOL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pool Corporation

POOL

Pool Corporation

HOLD

Current Price

$240.22

Market Cap

11.6B

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$58.47

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POOL
TECH
Founded
1993
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6B
9.5B
IPO Year
1995
1989

Fundamental Metrics

Financial Performance
Metric
POOL
TECH
Price
$240.22
$58.47
Analyst Decision
Hold
Strong Buy
Analyst Count
9
14
Target Price
$338.33
$71.23
AVG Volume (30 Days)
814.5K
1.7M
Earning Date
10-23-2025
11-05-2025
Dividend Yield
2.08%
0.55%
EPS Growth
N/A
N/A
EPS
10.93
0.49
Revenue
$5,294,666,000.00
$1,216,732,000.00
Revenue This Year
$1.92
$2.33
Revenue Next Year
$3.55
$7.05
P/E Ratio
$21.99
$120.22
Revenue Growth
N/A
3.85
52 Week Low
$229.63
$46.01
52 Week High
$374.74
$79.28

Technical Indicators

Market Signals
Indicator
POOL
TECH
Relative Strength Index (RSI) 40.55 41.76
Support Level $232.83 $58.75
Resistance Level $246.13 $61.20
Average True Range (ATR) 5.97 2.02
MACD 1.73 -0.49
Stochastic Oscillator 39.11 2.94

Price Performance

Historical Comparison
POOL
TECH

About POOL Pool Corporation

Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: